The quarter beat on sales but missed on earnings. Revenue of $807.6 million exceeded the published expectation of roughly $749 million, while core adjusted EPS of $1.33 came in below the approximately $1.38 consensus. That is a strong top-line surprise, but not an earnings beat.
| Metric | Q2 2026 | Q2 2025 | Market expectation |
|---|---|---|---|
| Net sales | $807.6M (Financial Statements) | $715.6M (Financial Statements) | ~$749.1M |
| Core organic sales growth | 2.5% (Core Sales) | 2.5% (Core Sales) | — |
| Core adjusted EBITDA | $149.6M (Segment Results) | $138.5M (Segment Results) | — |
| Core adjusted EBITDA margin | 19.5% (Segment Results) | 20.4% (Segment Results) | — |
| Core adjusted EPS | $1.33 (Adjusted Net Income) | $1.36 (Adjusted Net Income) | ~$1.38 |
| Operating cash flow | $33.4M (Cash Flow statement) | $46.6M (Cash Flow statement) | — |
The underlying business improved, but the quality of growth was uneven. Core organic sales rose 2.5%, with strength in the Americas and a return to growth in EMEA & APAC; however, acquisitions and currency supplied most of the 12.9% reported sales increase. Core adjusted EBITDA rose 8.0%, but the margin contracted 90 basis points to 19.5% because of pricing and cost pressure plus commercial investment. (Core Sales) (Segment Results)
The guidance change is the more important signal. ESAB raised 2026 core sales growth to 11%-14% from 6%-9% and core adjusted EBITDA to $615-$625 million from $575-$595 million, largely because expected acquisition contribution increased to approximately 9% from 4%. But it simultaneously cut core adjusted EPS guidance to $5.40-$5.50 from $5.70-$5.90. (2026 Outlook) The combination implies that the added acquisition earnings are being offset at the per-share level by higher financing costs, amortization, integration costs and dilution.
The balance sheet makes that EPS reset understandable. Six-month acquisition spending reached $1.47 billion, funded alongside $1.00 billion of senior notes, additional revolver activity and $175 million of mandatory convertible preferred stock. Long-term debt rose to $2.39 billion from $1.23 billion at year-end, while MCPS dividends reduced common-stock earnings. (Cash Flow statement) (Balance Sheet) The net read is therefore unfavorable versus expectations: strong revenue and acquisition momentum, but weaker margins, a quarterly EPS miss and a lower full-year EPS outlook despite higher EBITDA guidance.
Read the original 8-K on SEC EDGAR ↗